Research & Development Activitiessaiwpadminwam2019-08-14T17:32:36+00:00
Sysmex RDCA is endeavoring to create new clinical value for personalized medicine through open innovation – generating synergy by combining the technology and knowledge possessed by universities and research institutes with our own.
Our R&D Activities Through Open Innovation Include:
Research and Development of applications in a variety of disease fields using our technology platforms such as for genes, cells and proteins.
Gene Measurement Technolgies
Gene analysis technologies for personalized medicine, such as prediction of onset, recurrence risk and therapeutic efﬁcacy.